Terms: = Kidney tumors AND RHOH, TTF, 399, ENSG00000168421, ARHH, RhoH AND Prognosis
15 results:
1. Extracranial malignant rhabdoid tumors in children: high mortality even with the help of an aggressive clinical approach.
Xie S; Fang Y; Yang Y; Liu L; Bai J; Lin S; Zhang B; Fang Y
Eur J Pediatr; 2024 Feb; 183(2):557-567. PubMed ID: 38019286
[TBL] [Abstract] [Full Text] [Related]
2. Metastases to the kidney from primary lung cancer : clinicopathological analysis of six cases in a single center.
Lian H; Pan X; Hong B; Min J; Huang F
Diagn Pathol; 2023 May; 18(1):60. PubMed ID: 37161448
[TBL] [Abstract] [Full Text] [Related]
3. A novel gene signature related to oxidative stress predicts the prognosis in clear cell renal cell carcinoma.
Ma S; Ge Y; Xiong Z; Wang Y; Li L; Chao Z; Li B; Zhang J; Ma S; Xiao J; Liu B; Wang Z
PeerJ; 2023; 11():e14784. PubMed ID: 36785707
[TBL] [Abstract] [Full Text] [Related]
4. Collecting duct carcinoma: Epidemiology, clinical characteristics and survival.
Panunzio A; Tappero S; Hohenhorst L; Cano Garcia C; Piccinelli M; Barletta F; Tian Z; Tafuri A; Briganti A; De Cobelli O; Chun FKH; Tilki D; Terrone C; Kapoor A; Saad F; Shariat SF; Cerruto MA; Antonelli A; Karakiewicz PI
Urol Oncol; 2023 Feb; 41(2):110.e7-110.e14. PubMed ID: 36456452
[TBL] [Abstract] [Full Text] [Related]
5. The tumor microenvironment and prognostic role of autophagy- and immune-related genes in bladder cancer.
Gao Z; Chen C; Gu P; Chen J; Liu X; Shen J
Cancer Biomark; 2022; 35(3):293-303. PubMed ID: 36245371
[TBL] [Abstract] [Full Text] [Related]
6. The clinical significance, immune infiltration, and tumor mutational burden of angiogenesis-associated lncRNAs in kidney renal clear cell carcinoma.
Zhang W; Liu Z; Wang J; Geng B; Hou W; Zhao E; Li X
Front Immunol; 2022; 13():934387. PubMed ID: 35958561
[TBL] [Abstract] [Full Text] [Related]
7. Plasmacytoid/diffuse urothelial carcinoma: a single-institution immunohistochemical and molecular study of 69 patients.
Perrino CM; Eble J; Kao CS; Whaley RD; Cheng L; Idrees M; Hashemi-Sadraei N; Monn MF; Kaimakliotis HZ; Bandali E; Grignon D
Hum Pathol; 2019 Aug; 90():27-36. PubMed ID: 31054897
[TBL] [Abstract] [Full Text] [Related]
8. Metastatic Chromophobe Renal Cell Carcinoma: Presence or Absence of Sarcomatoid Differentiation Determines Clinical Course and Treatment Outcomes.
Ged Y; Chen YB; Knezevic A; Casuscelli J; Redzematovic A; DiNatale RG; Carlo MI; Lee CH; Feldman DR; Patil S; Hakimi AA; Russo P; Motzer RJ; Voss MH
Clin Genitourin Cancer; 2019 Jun; 17(3):e678-e688. PubMed ID: 31036466
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic Significance of Macroscopic Appearance in Clear Cell Renal Cell Carcinoma and Its Metastasis-Predicting Model.
Jeong SU; Park JM; Shin SJ; Lee J; Song C; Go H; Cho NH; Ro JY; Cho YM
Pathol Int; 2017 Dec; 67(12):610-619. PubMed ID: 29086465
[TBL] [Abstract] [Full Text] [Related]
10. Opposite prognostic roles of HIF1α and HIF2α expressions in bone metastatic clear cell renal cell cancer.
Szendrői A; Szász AM; Kardos M; Tőkés AM; Idan R; Szűcs M; Kulka J; Nyirády P; Szendrői M; Szállási Z; Győrffy B; Tímár J
Oncotarget; 2016 Jul; 7(27):42086-42098. PubMed ID: 27244898
[TBL] [Abstract] [Full Text] [Related]
11. Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: characterization of survival outcome and application of the International mRCC Database Consortium criteria.
Kroeger N; Xie W; Lee JL; Bjarnason GA; Knox JJ; Mackenzie MJ; Wood L; Srinivas S; Vaishamayan UN; Rha SY; Pal SK; Yuasa T; Donskov F; Agarwal N; Kollmannsberger CK; Tan MH; North SA; Rini BI; Choueiri TK; Heng DY
Cancer; 2013 Aug; 119(16):2999-3006. PubMed ID: 23696129
[TBL] [Abstract] [Full Text] [Related]
12. MYBPH, a transcriptional target of ttf-1, inhibits ROCK1, and reduces cell motility and metastasis.
Hosono Y; Yamaguchi T; Mizutani E; Yanagisawa K; Arima C; Tomida S; Shimada Y; Hiraoka M; Kato S; Yokoi K; Suzuki M; Takahashi T
EMBO J; 2012 Jan; 31(2):481-93. PubMed ID: 22085929
[TBL] [Abstract] [Full Text] [Related]
13. Primary tumor prevalence has an impact on the constituent ratio of metastases to the jaw but not on metastatic sites.
Zhang FG; Hua CG; Shen ML; Tang XF
Int J Oral Sci; 2011 Jul; 3(3):141-52. PubMed ID: 21789963
[TBL] [Abstract] [Full Text] [Related]
14. A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings.
Oudard S; Rixe O; Beuselinck B; Linassier C; Banu E; Machiels JP; Baudard M; Ringeisen F; Velu T; Lefrere-Belda MA; Limacher JM; Fridman WH; Azizi M; Acres B; Tartour E
Cancer Immunol Immunother; 2011 Feb; 60(2):261-71. PubMed ID: 21069322
[TBL] [Abstract] [Full Text] [Related]
15. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
[TBL] [Abstract] [Full Text] [Related]
